Aristotle Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $206K | Sell |
|
|||||
|
2024
Q2 | $210K | Sell |
|
|||||
|
2024
Q1 | $43.2M | Sell |
|
|||||
|
2023
Q4 | $59.8M | Buy |
|
|||||
|
2023
Q3 | $60M | Buy |
|
|||||
|
2023
Q2 | $59.2M | Buy |
|
|||||
|
2023
Q1 | $52.5M | Buy |
|
|||||
|
2022
Q4 | $51.1M | Sell |
|
|||||
|
2022
Q3 | $44.5M | Sell |
|
|||||
|
2022
Q2 | $50.3M | Buy |
|
|||||
|
2022
Q1 | $51.4M | Buy |
|
|||||
|
2021
Q4 | $49.2M | Sell |
|
|||||
|
2021
Q3 | $665M | Buy |
|
|||||
|
2021
Q2 | $736M | Buy |
|
|||||
|
2021
Q1 | $676M | Buy |
|
|||||
|
2020
Q4 | $672M | Buy |
|
|||||
|
2020
Q3 | $588M | Buy |
|
|||||
|
2020
Q2 | $574M | Buy |
|
|||||
|
2020
Q1 | $485M | Buy |
|
|||||
|
2019
Q4 | $548M | Buy |
|
|||||
|
2019
Q3 | $305M | Buy |
|
|||||
|
2019
Q2 | $310M | Sell |
|
|||||
|
2019
Q1 | $336M | Buy |
|
|||||
|
2018
Q4 | $263M | Sell |
|
|||||
|
2018
Q3 | $315M | Sell |
|
|||||
|
2018
Q2 | $278M | Buy |
|
|||||
|
2018
Q1 | $275M | Buy |
|
|||||
|
2017
Q4 | $268M | Buy |
|
|||||
|
2017
Q3 | $256M | Sell |
|
|||||
|
2017
Q2 | $249M | Buy |
|
|||||
|
2017
Q1 | $213M | Buy |
|
|||||
|
2016
Q4 | $201M | Buy |
|
|||||
|
2016
Q3 | $214M | Sell |
|
|||||
|
2016
Q2 | $226M | Buy |
|
|||||
|
2016
Q1 | $150M | Buy |
|
|||||
|
2015
Q4 | $162M | Buy |
|
|||||
|
2015
Q3 | $167M | Buy |
|
|||||
|
2015
Q2 | $177M | Buy |
|
|||||
|
2015
Q1 | $176M | Buy |
|
|||||
|
2014
Q4 | $13.6M | Buy |
|
|||||
|
2014
Q3 | $13.4M | Buy |
|
|||||
|
2014
Q2 | $11.8M | Sell |
|
|||||
|
2014
Q1 | $17.3M | Buy |
|
|||||
|
2013
Q4 | $10M | Buy |
|
|||||
|
2013
Q3 | $4.39M | Buy |
|
|||||
|
2013
Q2 | $2.12M | Buy |
|